M. Oksman

发表

Effect of Physical Properties and Emulsification Conditions on the Microsphere Size Prepared Using a Solvent Extraction Process

H. Heiskanen, M. Hurme, Päivi Pitkänen, 2012 .

Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice

H. Tanila, E. Machová, J. Jakubík, 2008, Neurobiology of Aging.

OLIGOMERIZATION OF ETHYLENE WITH CATIONIC PHENANTHROLINE(METHYL)PALLADIUM COMPLEXES

T. Bártfai, Ü. Langel, S. Strömberg, 1995 .

A New Heterogenization Technique for Single‐Site Polymerization Catalysts

Peter Denifl, M. Oksman, M. Bartke, 2005 .

Brain reward in the absence of alpha-synuclein

Heikki Tanila, H. Tanila, Leonid Yavich, 2006, Neuroreport.

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human α-synuclein

Heikki Tanila, Jukka Puoliväli, Mikko Hiltunen, 2005, Neurobiology of Disease.

Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice

H. Tanila, B. Penke, T. Hartmann, 2006, Neurobiology of Disease.

Spermidine/spermine N 1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment

H. Tanila, L. Alhonen, S. K. Kaasinen, 2004, Pharmacology Biochemistry and Behavior.

Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA

H. Tanila, L. Yavich, M. Oksman, 2009, Neuropharmacology.

Transduced Wild-Type but Not P301S Mutated Human Tau Shows Hyperphosphorylation in Transgenic Mice Overexpressing A30P Mutated Human Alpha-Synuclein

H. Tanila, P. Miettinen, D. Kirik, 2012, Neurodegenerative Diseases.